4/25/2017

Gadoteridol Injection

Reason for the Shortage

- Bracco Diagnostics has ProHance available.

Available Products

- ProHance intravenous solution for injection, Bracco Diagnostics, 279.3 mg/mL, 10 mL prefilled syringe, 5 count, NDC 00270-1111-16
- ProHance intravenous solution for injection, Bracco Diagnostics, 279.3 mg/mL, 10 mL vial, 5 count, NDC 00270-1111-01
- ProHance intravenous solution for injection, Bracco Diagnostics, 279.3 mg/mL, 15 mL vial, 5 count, NDC 00270-1111-02
- ProHance intravenous solution for injection, Bracco Diagnostics, 279.3 mg/mL, 17 mL prefilled syringe, 5 count, NDC 00270-1111-45
- ProHance intravenous solution for injection, Bracco Diagnostics, 279.3 mg/mL, 20 mL vial, 5 count, NDC 00270-1111-03
- ProHance intravenous solution for injection, Bracco Diagnostics, 279.3 mg/mL, 5 mL vial, 5 count, NDC 00270-1111-04
- ProHance intravenous solution for injection, Bracco Diagnostics, 279.3 mg/mL, 50 mL bulk vial, 5 count, NDC 00270-1111-70

Updated

Updated April 25, 2017 by Leslie Jensen, PharmD, Drug Information Specialist. Created April 26, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.